NO307463B1 - Galantaminderivater, en fremgangsmõte for fremstilling samt deres anvendelse som medikamenter - Google Patents
Galantaminderivater, en fremgangsmõte for fremstilling samt deres anvendelse som medikamenterInfo
- Publication number
- NO307463B1 NO307463B1 NO943894A NO943894A NO307463B1 NO 307463 B1 NO307463 B1 NO 307463B1 NO 943894 A NO943894 A NO 943894A NO 943894 A NO943894 A NO 943894A NO 307463 B1 NO307463 B1 NO 307463B1
- Authority
- NO
- Norway
- Prior art keywords
- drugs
- preparation
- alkylaminocarbonyloxy
- galantamine derivatives
- alkylaminocarbonyl
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical class O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title 1
- 125000005195 alkyl amino carbonyloxy group Chemical group 0.000 abstract 3
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/137,443 US6323196B1 (en) | 1993-10-15 | 1993-10-15 | Galanthamine derivatives as acetylcholinesterase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO943894D0 NO943894D0 (no) | 1994-10-14 |
| NO943894L NO943894L (no) | 1995-04-18 |
| NO307463B1 true NO307463B1 (no) | 2000-04-10 |
Family
ID=22477457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943894A NO307463B1 (no) | 1993-10-15 | 1994-10-14 | Galantaminderivater, en fremgangsmõte for fremstilling samt deres anvendelse som medikamenter |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6323196B1 (pl) |
| EP (2) | EP1020469A3 (pl) |
| JP (1) | JP2718637B2 (pl) |
| KR (1) | KR100189043B1 (pl) |
| CN (1) | CN1039011C (pl) |
| AT (1) | ATE201687T1 (pl) |
| AU (1) | AU679560B2 (pl) |
| CA (1) | CA2118171C (pl) |
| CZ (1) | CZ283561B6 (pl) |
| DE (1) | DE69427332T2 (pl) |
| DK (1) | DK0648771T3 (pl) |
| EG (1) | EG20747A (pl) |
| ES (1) | ES2158876T3 (pl) |
| FI (1) | FI108724B (pl) |
| GR (1) | GR3036068T3 (pl) |
| IL (1) | IL111273A (pl) |
| NO (1) | NO307463B1 (pl) |
| NZ (1) | NZ264681A (pl) |
| PL (1) | PL177754B1 (pl) |
| PT (1) | PT648771E (pl) |
| RO (1) | RO114132B1 (pl) |
| RU (1) | RU2113438C1 (pl) |
| TW (1) | TW375615B (pl) |
| ZA (1) | ZA948060B (pl) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT403803B (de) | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
| WO2000030446A1 (en) | 1998-11-23 | 2000-06-02 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
| EP1140105B1 (en) | 1998-12-24 | 2003-10-22 | Janssen Pharmaceutica N.V. | Controlled release galantamine composition |
| AU780012B2 (en) * | 1999-12-10 | 2005-02-24 | Bonnie Davis | Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| CN1380883A (zh) | 2000-03-31 | 2002-11-20 | 萨诺化学药物股份公司 | 雪花胺的新衍生物和类似物 |
| US20030162770A1 (en) * | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| US20040142970A1 (en) * | 2002-11-01 | 2004-07-22 | Kathryn Chung | Treatment of hyperkinetic movement disorder with donepezil |
| US20050048543A1 (en) * | 2003-07-11 | 2005-03-03 | Jeroen Aerssens | CHRNA2 genetic markers associated with galantamine response |
| WO2005042762A2 (en) * | 2003-10-28 | 2005-05-12 | Genaissance Pharmaceuticals, Inc. | Lrpap1 genetic markers associated with galantamine response |
| US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
| US7250258B2 (en) * | 2003-12-15 | 2007-07-31 | Pgxhealth Llc | CDK5 genetic markers associated with galantamine response |
| CA2552114A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
| US20050191349A1 (en) * | 2003-12-31 | 2005-09-01 | Garth Boehm | Galantamine formulations |
| EP1779867A4 (en) * | 2004-07-01 | 2009-12-02 | Eisai R&D Man Co Ltd | MEANS FOR PROMOTING NERVE REVENERATION |
| DK1895994T3 (da) * | 2005-05-13 | 2010-12-20 | Alza Corp | Multilagsmedikamentleveringssystem med barriere mod reservoirmaterialeflow |
| US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
| EP1777222A1 (en) * | 2005-09-22 | 2007-04-25 | Galantos Pharma GmbH | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
| KR100786371B1 (ko) * | 2006-12-07 | 2007-12-17 | 한국화학연구원 | 갈란타민의 제조방법 |
| EP2137192B8 (en) | 2008-04-14 | 2014-06-11 | Neurodyn Life Sciences Inc. | Derivatives of galantamine as pro-drugs for the treatment of human brain diseases |
| US20120184532A1 (en) * | 2009-07-23 | 2012-07-19 | Shire Llc | Galantamine amino acid and peptide prodrugs and uses thereof |
| US12551491B1 (en) * | 2025-07-23 | 2026-02-17 | Alpha Cognition Inc. | Dosage regimens for benzgalantamine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL122665B1 (en) | 1978-11-21 | 1982-08-31 | Edinen Zentar Chim | Process for preparing novel dienones of narvedine type and their derivatives |
| US4663318A (en) | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
| US6150354A (en) * | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
| DE3856594D1 (de) * | 1987-05-04 | 2008-11-27 | Bonnie Davis | Mittel zur behandlung der alzheimer-krankheit |
| NL8800350A (nl) | 1988-02-12 | 1989-09-01 | Stichting Biomedical Research | Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen. |
| DE69229781T2 (de) | 1991-05-14 | 2000-01-05 | Ernir Snorrason | Behandlung des ermüdungssyndroms mit cholinesteraseinhibitoren |
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
| US5231093A (en) * | 1991-10-01 | 1993-07-27 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
-
1993
- 1993-10-15 US US08/137,443 patent/US6323196B1/en not_active Expired - Lifetime
-
1994
- 1994-10-10 PT PT94115960T patent/PT648771E/pt unknown
- 1994-10-10 EP EP00107569A patent/EP1020469A3/en not_active Withdrawn
- 1994-10-10 DK DK94115960T patent/DK0648771T3/da active
- 1994-10-10 EP EP94115960A patent/EP0648771B1/en not_active Expired - Lifetime
- 1994-10-10 AT AT94115960T patent/ATE201687T1/de active
- 1994-10-10 ES ES94115960T patent/ES2158876T3/es not_active Expired - Lifetime
- 1994-10-10 DE DE69427332T patent/DE69427332T2/de not_active Expired - Lifetime
- 1994-10-12 EG EG63794A patent/EG20747A/xx active
- 1994-10-13 NZ NZ264681A patent/NZ264681A/en not_active IP Right Cessation
- 1994-10-13 RU RU94036761A patent/RU2113438C1/ru active
- 1994-10-13 IL IL111273A patent/IL111273A/en not_active IP Right Cessation
- 1994-10-13 FI FI944822A patent/FI108724B/fi not_active IP Right Cessation
- 1994-10-14 RO RO94-01668A patent/RO114132B1/ro unknown
- 1994-10-14 AU AU75812/94A patent/AU679560B2/en not_active Expired
- 1994-10-14 PL PL94305455A patent/PL177754B1/pl unknown
- 1994-10-14 CA CA002118171A patent/CA2118171C/en not_active Expired - Lifetime
- 1994-10-14 CN CN94117061A patent/CN1039011C/zh not_active Expired - Lifetime
- 1994-10-14 KR KR1019940026304A patent/KR100189043B1/ko not_active Expired - Lifetime
- 1994-10-14 TW TW083109528A patent/TW375615B/zh not_active IP Right Cessation
- 1994-10-14 CZ CZ942547A patent/CZ283561B6/cs not_active IP Right Cessation
- 1994-10-14 ZA ZA948060A patent/ZA948060B/xx unknown
- 1994-10-14 NO NO943894A patent/NO307463B1/no not_active IP Right Cessation
- 1994-10-17 JP JP6250776A patent/JP2718637B2/ja not_active Expired - Fee Related
-
2001
- 2001-06-19 GR GR20010400911T patent/GR3036068T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO943894L (no) | Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter | |
| NO943893L (no) | Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter | |
| LU91210I2 (fr) | Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER) | |
| AU7350694A (en) | Remedy for nervous diseases | |
| DK0850926T3 (da) | Difluorprostaglandinderivater og deres anvendelse | |
| DK1104760T3 (da) | Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler | |
| AU1433588A (en) | 1-phenyl-3-naphthalenyloxypropanamines | |
| PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
| DK0695755T3 (da) | Pyrrolocarbazoler | |
| NO943895D0 (no) | Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter | |
| DK0743319T3 (da) | Benzokondenserede azepinon- og piperidinonforbindelser, der er nyttige som ACE- og NEP-inhibitorer | |
| AU5928186A (en) | Biocidal mixture | |
| ES2054806T3 (es) | Cicloalquilamidas de (8beta)-1-alquil-6-(sustituido)-ergolinas. | |
| EP1034783A4 (en) | AMIDE DERIVATIVES | |
| NO20052360L (no) | Forbedrede formuleringer inneholdende substituerte imidazolderivater | |
| EP0555479A4 (pl) | ||
| ES2149180T3 (es) | Derivado de pirazolotiazolopirimidina. | |
| DK0998464T3 (da) | Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser | |
| DK0638587T3 (da) | Salmyciner, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |